Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List

Abstract Introduction To examine whether the official adoption of Model for End-Stage Liver Disease (MELD) as a criterion for organ allocation was effective, we studied risk factors for patient deaths and the accuracy of the MELD score to predict mortality. Methods Patients on the waiting list for l...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation proceedings 2010-03, Vol.42 (2), p.412-416
Hauptverfasser: Castro, R.S, Deisanti, D, Seva-Pereira, T, Almeida, J.R.S, Yamanaka, A, Boin, I.F.S.F, Soares, E.C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 416
container_issue 2
container_start_page 412
container_title Transplantation proceedings
container_volume 42
creator Castro, R.S
Deisanti, D
Seva-Pereira, T
Almeida, J.R.S
Yamanaka, A
Boin, I.F.S.F
Soares, E.C
description Abstract Introduction To examine whether the official adoption of Model for End-Stage Liver Disease (MELD) as a criterion for organ allocation was effective, we studied risk factors for patient deaths and the accuracy of the MELD score to predict mortality. Methods Patients on the waiting list for liver transplantation were divided into two periods depending on whether they were on the waiting list before (period 1) or after (period 2) the MELD introduction in Brazil. The Kaplan-Meier method with log-rank tests were used to study patient survivals. Predictive factors were identified using the Cox regression method. A receiver operating characteristic (ROC) curve was used to analyze Child-Turcotte-Pugh (CTP) and MELD accuracy. Results We analyzed 295 patients in period 1 and 240 in period 2. The survivals after 3, 6, 9, and 12 months in periods 1 and 2, were 95.6%, 90.5%, 84.9%, and 69.6% vs 95.7%, 92.1%, 85.3%, and 83.3%, respectively ( P = NS). Multivariate analysis showed CTP, MELD-Na, and albumin levels, besides spontaneous bacterial peritonitis (SBP), to be independent factors related to survival in period 1. In period 2, CTP, creatinine levels, international normalized ratio, besides spontaneous bacterial peritonitis, were the independent factors. The ROC curve for CTP was 0.676 and for MELD, 0.644 ( P = .4) in period 1. In period 2, the ROC curve for CTP was 0.680 and for MELD, 0.718 ( P = .4). Conclusion Patient survival on the waiting list for liver transplantation did not change at 1 year after the introduction of the MELD.
doi_str_mv 10.1016/j.transproceed.2010.01.028
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733808649</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0041134510001193</els_id><sourcerecordid>733808649</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-826803c3176763fd798beecda15d4703738c675688d0a40879816b9cc733dbb93</originalsourceid><addsrcrecordid>eNqNkk-LFDEQxYMo7rj6FSQI4qnHpJNJZzwI-09dGPEwKx5DOqleM_akd5P0wAp-d6t3ZlE8CYGQvFevih9FyCvO5pxx9XYzL8nGfJMGB-DnNUOB8Tmr9SMy47oRVa1q8ZjMGJO84kIujsiznDcM37UUT8lRzQRKCzEjv9Zj2oWd7ekpdEMCaqOnJ12BRD8PHnqKn_Qi-ioXew10FXaonIcMNgNdu6niMpY0-NGVMESKp3wHeprsz9AHGw8VV_cD9zYW-s2GEuI1Crk8J08622d4cbiPydcPF1dnn6rVl4-XZyerykklS6VrpZlwgjeqUaLzzVK3AM5bvvCyYaIR2qlmobT2zEqmUeeqXTrXCOHbdimOyZt9LjK7HSEXsw3ZQY8DwTBmgz7NtJKT893e6dKQc4LO3KSwtenOcGYm-mZj_qZvJvqGcYP0sfjloc3YblF7KH3AjYbXB4PNzvYdBrmQ__jqRkp9H3S-9wFC2QVIJrsA0YEPCVwxfgj_N8_7f2JcH2LAzj_gDvJmGFNE7IabXBtm1tO-TOvCcVM4XwrxG4i9vsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733808649</pqid></control><display><type>article</type><title>Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Castro, R.S ; Deisanti, D ; Seva-Pereira, T ; Almeida, J.R.S ; Yamanaka, A ; Boin, I.F.S.F ; Soares, E.C</creator><creatorcontrib>Castro, R.S ; Deisanti, D ; Seva-Pereira, T ; Almeida, J.R.S ; Yamanaka, A ; Boin, I.F.S.F ; Soares, E.C</creatorcontrib><description>Abstract Introduction To examine whether the official adoption of Model for End-Stage Liver Disease (MELD) as a criterion for organ allocation was effective, we studied risk factors for patient deaths and the accuracy of the MELD score to predict mortality. Methods Patients on the waiting list for liver transplantation were divided into two periods depending on whether they were on the waiting list before (period 1) or after (period 2) the MELD introduction in Brazil. The Kaplan-Meier method with log-rank tests were used to study patient survivals. Predictive factors were identified using the Cox regression method. A receiver operating characteristic (ROC) curve was used to analyze Child-Turcotte-Pugh (CTP) and MELD accuracy. Results We analyzed 295 patients in period 1 and 240 in period 2. The survivals after 3, 6, 9, and 12 months in periods 1 and 2, were 95.6%, 90.5%, 84.9%, and 69.6% vs 95.7%, 92.1%, 85.3%, and 83.3%, respectively ( P = NS). Multivariate analysis showed CTP, MELD-Na, and albumin levels, besides spontaneous bacterial peritonitis (SBP), to be independent factors related to survival in period 1. In period 2, CTP, creatinine levels, international normalized ratio, besides spontaneous bacterial peritonitis, were the independent factors. The ROC curve for CTP was 0.676 and for MELD, 0.644 ( P = .4) in period 1. In period 2, the ROC curve for CTP was 0.680 and for MELD, 0.718 ( P = .4). Conclusion Patient survival on the waiting list for liver transplantation did not change at 1 year after the introduction of the MELD.</description><identifier>ISSN: 0041-1345</identifier><identifier>EISSN: 1873-2623</identifier><identifier>DOI: 10.1016/j.transproceed.2010.01.028</identifier><identifier>PMID: 20304153</identifier><identifier>CODEN: TRPPA8</identifier><language>eng</language><publisher>Amsterdam: Elsevier Inc</publisher><subject>Adult ; Bilirubin - blood ; Biological and medical sciences ; Brazil ; Creatinine - blood ; Female ; Fundamental and applied biological sciences. Psychology ; Fundamental immunology ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Liver Diseases - classification ; Liver Diseases - surgery ; Liver Failure - mortality ; Liver Failure - surgery ; Liver Transplantation - statistics &amp; numerical data ; Liver. Biliary tract. Portal circulation. Exocrine pancreas ; Male ; Medical sciences ; Middle Aged ; Models, Biological ; Other diseases. Semiology ; Predictive Value of Tests ; Regression Analysis ; ROC Curve ; Serum Albumin - metabolism ; Surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Survival Rate ; Survivors ; Time Factors ; Tissue, organ and graft immunology ; Waiting Lists</subject><ispartof>Transplantation proceedings, 2010-03, Vol.42 (2), p.412-416</ispartof><rights>Elsevier Inc.</rights><rights>2010 Elsevier Inc.</rights><rights>2015 INIST-CNRS</rights><rights>Copyright (c) 2010 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-826803c3176763fd798beecda15d4703738c675688d0a40879816b9cc733dbb93</citedby><cites>FETCH-LOGICAL-c464t-826803c3176763fd798beecda15d4703738c675688d0a40879816b9cc733dbb93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0041134510001193$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,776,780,785,786,3537,23909,23910,25118,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22744828$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20304153$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Castro, R.S</creatorcontrib><creatorcontrib>Deisanti, D</creatorcontrib><creatorcontrib>Seva-Pereira, T</creatorcontrib><creatorcontrib>Almeida, J.R.S</creatorcontrib><creatorcontrib>Yamanaka, A</creatorcontrib><creatorcontrib>Boin, I.F.S.F</creatorcontrib><creatorcontrib>Soares, E.C</creatorcontrib><title>Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List</title><title>Transplantation proceedings</title><addtitle>Transplant Proc</addtitle><description>Abstract Introduction To examine whether the official adoption of Model for End-Stage Liver Disease (MELD) as a criterion for organ allocation was effective, we studied risk factors for patient deaths and the accuracy of the MELD score to predict mortality. Methods Patients on the waiting list for liver transplantation were divided into two periods depending on whether they were on the waiting list before (period 1) or after (period 2) the MELD introduction in Brazil. The Kaplan-Meier method with log-rank tests were used to study patient survivals. Predictive factors were identified using the Cox regression method. A receiver operating characteristic (ROC) curve was used to analyze Child-Turcotte-Pugh (CTP) and MELD accuracy. Results We analyzed 295 patients in period 1 and 240 in period 2. The survivals after 3, 6, 9, and 12 months in periods 1 and 2, were 95.6%, 90.5%, 84.9%, and 69.6% vs 95.7%, 92.1%, 85.3%, and 83.3%, respectively ( P = NS). Multivariate analysis showed CTP, MELD-Na, and albumin levels, besides spontaneous bacterial peritonitis (SBP), to be independent factors related to survival in period 1. In period 2, CTP, creatinine levels, international normalized ratio, besides spontaneous bacterial peritonitis, were the independent factors. The ROC curve for CTP was 0.676 and for MELD, 0.644 ( P = .4) in period 1. In period 2, the ROC curve for CTP was 0.680 and for MELD, 0.718 ( P = .4). Conclusion Patient survival on the waiting list for liver transplantation did not change at 1 year after the introduction of the MELD.</description><subject>Adult</subject><subject>Bilirubin - blood</subject><subject>Biological and medical sciences</subject><subject>Brazil</subject><subject>Creatinine - blood</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Fundamental immunology</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Liver Diseases - classification</subject><subject>Liver Diseases - surgery</subject><subject>Liver Failure - mortality</subject><subject>Liver Failure - surgery</subject><subject>Liver Transplantation - statistics &amp; numerical data</subject><subject>Liver. Biliary tract. Portal circulation. Exocrine pancreas</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Models, Biological</subject><subject>Other diseases. Semiology</subject><subject>Predictive Value of Tests</subject><subject>Regression Analysis</subject><subject>ROC Curve</subject><subject>Serum Albumin - metabolism</subject><subject>Surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Survival Rate</subject><subject>Survivors</subject><subject>Time Factors</subject><subject>Tissue, organ and graft immunology</subject><subject>Waiting Lists</subject><issn>0041-1345</issn><issn>1873-2623</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkk-LFDEQxYMo7rj6FSQI4qnHpJNJZzwI-09dGPEwKx5DOqleM_akd5P0wAp-d6t3ZlE8CYGQvFevih9FyCvO5pxx9XYzL8nGfJMGB-DnNUOB8Tmr9SMy47oRVa1q8ZjMGJO84kIujsiznDcM37UUT8lRzQRKCzEjv9Zj2oWd7ekpdEMCaqOnJ12BRD8PHnqKn_Qi-ioXew10FXaonIcMNgNdu6niMpY0-NGVMESKp3wHeprsz9AHGw8VV_cD9zYW-s2GEuI1Crk8J08622d4cbiPydcPF1dnn6rVl4-XZyerykklS6VrpZlwgjeqUaLzzVK3AM5bvvCyYaIR2qlmobT2zEqmUeeqXTrXCOHbdimOyZt9LjK7HSEXsw3ZQY8DwTBmgz7NtJKT893e6dKQc4LO3KSwtenOcGYm-mZj_qZvJvqGcYP0sfjloc3YblF7KH3AjYbXB4PNzvYdBrmQ__jqRkp9H3S-9wFC2QVIJrsA0YEPCVwxfgj_N8_7f2JcH2LAzj_gDvJmGFNE7IabXBtm1tO-TOvCcVM4XwrxG4i9vsQ</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Castro, R.S</creator><creator>Deisanti, D</creator><creator>Seva-Pereira, T</creator><creator>Almeida, J.R.S</creator><creator>Yamanaka, A</creator><creator>Boin, I.F.S.F</creator><creator>Soares, E.C</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List</title><author>Castro, R.S ; Deisanti, D ; Seva-Pereira, T ; Almeida, J.R.S ; Yamanaka, A ; Boin, I.F.S.F ; Soares, E.C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-826803c3176763fd798beecda15d4703738c675688d0a40879816b9cc733dbb93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Bilirubin - blood</topic><topic>Biological and medical sciences</topic><topic>Brazil</topic><topic>Creatinine - blood</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Fundamental immunology</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Liver Diseases - classification</topic><topic>Liver Diseases - surgery</topic><topic>Liver Failure - mortality</topic><topic>Liver Failure - surgery</topic><topic>Liver Transplantation - statistics &amp; numerical data</topic><topic>Liver. Biliary tract. Portal circulation. Exocrine pancreas</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Models, Biological</topic><topic>Other diseases. Semiology</topic><topic>Predictive Value of Tests</topic><topic>Regression Analysis</topic><topic>ROC Curve</topic><topic>Serum Albumin - metabolism</topic><topic>Surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Survival Rate</topic><topic>Survivors</topic><topic>Time Factors</topic><topic>Tissue, organ and graft immunology</topic><topic>Waiting Lists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Castro, R.S</creatorcontrib><creatorcontrib>Deisanti, D</creatorcontrib><creatorcontrib>Seva-Pereira, T</creatorcontrib><creatorcontrib>Almeida, J.R.S</creatorcontrib><creatorcontrib>Yamanaka, A</creatorcontrib><creatorcontrib>Boin, I.F.S.F</creatorcontrib><creatorcontrib>Soares, E.C</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Transplantation proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Castro, R.S</au><au>Deisanti, D</au><au>Seva-Pereira, T</au><au>Almeida, J.R.S</au><au>Yamanaka, A</au><au>Boin, I.F.S.F</au><au>Soares, E.C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List</atitle><jtitle>Transplantation proceedings</jtitle><addtitle>Transplant Proc</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>42</volume><issue>2</issue><spage>412</spage><epage>416</epage><pages>412-416</pages><issn>0041-1345</issn><eissn>1873-2623</eissn><coden>TRPPA8</coden><abstract>Abstract Introduction To examine whether the official adoption of Model for End-Stage Liver Disease (MELD) as a criterion for organ allocation was effective, we studied risk factors for patient deaths and the accuracy of the MELD score to predict mortality. Methods Patients on the waiting list for liver transplantation were divided into two periods depending on whether they were on the waiting list before (period 1) or after (period 2) the MELD introduction in Brazil. The Kaplan-Meier method with log-rank tests were used to study patient survivals. Predictive factors were identified using the Cox regression method. A receiver operating characteristic (ROC) curve was used to analyze Child-Turcotte-Pugh (CTP) and MELD accuracy. Results We analyzed 295 patients in period 1 and 240 in period 2. The survivals after 3, 6, 9, and 12 months in periods 1 and 2, were 95.6%, 90.5%, 84.9%, and 69.6% vs 95.7%, 92.1%, 85.3%, and 83.3%, respectively ( P = NS). Multivariate analysis showed CTP, MELD-Na, and albumin levels, besides spontaneous bacterial peritonitis (SBP), to be independent factors related to survival in period 1. In period 2, CTP, creatinine levels, international normalized ratio, besides spontaneous bacterial peritonitis, were the independent factors. The ROC curve for CTP was 0.676 and for MELD, 0.644 ( P = .4) in period 1. In period 2, the ROC curve for CTP was 0.680 and for MELD, 0.718 ( P = .4). Conclusion Patient survival on the waiting list for liver transplantation did not change at 1 year after the introduction of the MELD.</abstract><cop>Amsterdam</cop><pub>Elsevier Inc</pub><pmid>20304153</pmid><doi>10.1016/j.transproceed.2010.01.028</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0041-1345
ispartof Transplantation proceedings, 2010-03, Vol.42 (2), p.412-416
issn 0041-1345
1873-2623
language eng
recordid cdi_proquest_miscellaneous_733808649
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
Bilirubin - blood
Biological and medical sciences
Brazil
Creatinine - blood
Female
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Gastroenterology. Liver. Pancreas. Abdomen
Humans
Liver Diseases - classification
Liver Diseases - surgery
Liver Failure - mortality
Liver Failure - surgery
Liver Transplantation - statistics & numerical data
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Middle Aged
Models, Biological
Other diseases. Semiology
Predictive Value of Tests
Regression Analysis
ROC Curve
Serum Albumin - metabolism
Surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Survival Rate
Survivors
Time Factors
Tissue, organ and graft immunology
Waiting Lists
title Survival Before and After Model for End-stage Liver Disease Score Introduction on the Brazilian Liver Transplant Waiting List
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T03%3A17%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survival%20Before%20and%20After%20Model%20for%20End-stage%20Liver%20Disease%20Score%20Introduction%20on%20the%20Brazilian%20Liver%20Transplant%20Waiting%20List&rft.jtitle=Transplantation%20proceedings&rft.au=Castro,%20R.S&rft.date=2010-03-01&rft.volume=42&rft.issue=2&rft.spage=412&rft.epage=416&rft.pages=412-416&rft.issn=0041-1345&rft.eissn=1873-2623&rft.coden=TRPPA8&rft_id=info:doi/10.1016/j.transproceed.2010.01.028&rft_dat=%3Cproquest_cross%3E733808649%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733808649&rft_id=info:pmid/20304153&rft_els_id=1_s2_0_S0041134510001193&rfr_iscdi=true